Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Archives of Drug Information|January 12, 2011
The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult SubjectsTae H Han, Rebecca L Blanchard, John Palcza, et al.
Cephalalgia : an International Journal of Headache|March 9, 2011
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraineDavid J Hewitt, Sheena K Aurora, David W Dodick, et al.
Lancet (London, England)|November 28, 2008
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trialTony W Ho, Michel D Ferrari, David W Dodick, et al.
The New England Journal of Medicine|February 17, 2005
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trialRobert S Bresalier, Robert S Sandler, Hui Quan, et al.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
Sleep|February 2, 2013
Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy menHong Sun, William P Kennedy, Darren Wilbraham, et al.
Cephalalgia : an International Journal of Headache|June 20, 2012
Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment designTony W Ho, Eric Pearlman, Donald Lewis, et al.
The Lancet. Neurology|April 1, 2014
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trialDavid Michelson, Ellen Snyder, Erin Paradis, et al.
Psychopharmacology|March 8, 2017
Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 dataW Joseph Herring, Kathryn M Connor, Ellen Snyder, et al.
Cephalalgia : an International Journal of Headache|May 1, 2015
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraineTony W Ho, Andrew P Ho, Yang Joy Ge, et al.
Pageof 6